Related Experiment Video

Updated: Aug 9, 2025

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
09:58

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis

Published on: June 27, 2020

2.8K

Deregulated E2F Activity as a Cancer-Cell Specific Therapeutic Tool

Rinka Nakajima1, Lin Zhao1, Yaxuan Zhou1

  • 1Department of Biomedical Sciences, School of Biological and Environmental Sciences, Kwansei Gakuin University, 1 Gakuen Uegahara, Sanda, Hyogo 669-1337, Japan.

Genes
|February 25, 2023
PubMed

Insights

Deregulated E2F activity, distinct from growth-stimulated E2F, uniquely targets cancer cells by activating tumor suppressor genes. This cancer-specific E2F activity offers a promising therapeutic strategy for cancer treatment.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Cell Cycle Regulation

Background:

  • The retinoblastoma protein (pRB) tumor suppressor regulates cell proliferation by controlling the E2F transcription factor.
  • Loss of pRB function and enhanced E2F activity are hallmarks of nearly all cancers.
  • Current therapeutic strategies targeting E2F in cancer may affect normal cells due to shared mechanisms of E2F activation.

Purpose of the Study:

  • To differentiate between E2F activity induced by growth stimulation and E2F activity resulting from pRB loss (deregulated E2F).
  • To investigate the potential of deregulated E2F activity as a cancer-specific therapeutic target.
  • To explore the unique molecular pathways activated by deregulated E2F in cancer cells.

Main Methods:

  • Comparative analysis of gene promoter activation by E2F under different cellular conditions (growth stimulation vs. pRB loss).
  • Examination of E2F dependency on its heterodimeric partner DP.
  • Assessment of ARF promoter activity as a specific marker for deregulated E2F.

Main Results:

  • Deregulated E2F, unlike growth-stimulated E2F, activates tumor suppressor genes, inducing senescence or apoptosis.
  • Cancer cells tolerate deregulated E2F due to ARF-p53 pathway inactivation, making it cancer-specific.
  • The ARF promoter exhibits higher cancer-cell specific activity compared to the E2F1 promoter, indicating selective activation by deregulated E2F.

Conclusions:

  • Deregulated E2F activity represents a unique molecular feature of cancer cells.
  • Targeting deregulated E2F offers a promising strategy for developing cancer-specific therapies.
  • This approach minimizes potential harm to normal proliferating cells.
Keywords:
ARFE2Fp53pRB

More Related Videos

Analysis of Cell Cycle Position in Mammalian Cells12:19

Analysis of Cell Cycle Position in Mammalian Cells

Published on: January 21, 2012

60.6K
Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

11.1K

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.5K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K